BioCryst Pharmaceuticals BCRX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$721.81M-2,255,763% | $245.85M+1,018% | $12.9M+192% | $5.09M+140% | $32K+100% | ||
| $461K+39.3% | $394K+27.5% | $335K+7.7% | $329K+2.8% | $331K+8.2% | ||
| $16.03M-25.0% | $23.79M+11.5% | $18.6M+7.8% | $21.3M+61.7% | $21.37M+56.5% | ||
| -$61.79M-125% | $291.96M+5,701% | $41.62M— | $41.3M+3,119% | -$27.52M+48.7% | ||
| $403K+182% | $802K+18.8% | $1.34M+2,178% | $179K+15.5% | $143K-39.1% | ||
| $489.48M— | —— | —— | —— | $0— | ||
| -$268.65M-1,092% | -$83.49M-569% | $13.57M+59.9% | $29.13M— | $27.1M-5.8% | ||
| $400M— | —— | —— | —— | $0— | ||
| $412.55M+77,887% | -$217.96M-5,321% | -$58.81M— | -$73.69M-3,648% | $529K+150% | ||
| $82.04M+14,603% | -$9.56M— | -$4.09M— | -$1.9M+68.0% | $558K+102% | ||
| -$62.19M-125% | $291.16M+5,045% | $40.28M— | $41.12M+2,800% | -$27.66M+48.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioCryst Pharmaceuticals generate?
- BioCryst Pharmaceuticals (BCRX) generated $313.1M in operating cash flow over the trailing twelve months.
- What is BioCryst Pharmaceuticals's free cash flow?
- After $2.7M of capital expenditures, BioCryst Pharmaceuticals's free cash flow was $310.4M over the trailing twelve months, up 448.8% year over year.
- Where does BioCryst Pharmaceuticals's cash flow data come from?
- Every line is extracted from BioCryst Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
